Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00374556 · ClinicalTrials.gov registry record · NA

Insomnia and Osteoarthritis Study

A NA study of Insomnia and Osteoarthritis, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00374556 is a NA study of Insomnia and Osteoarthritis that has completed, run by Johns Hopkins University. The registered enrollment target is 30 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00374556, a NA study of Insomnia and Osteoarthritis, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This research is being done to evaluate the effects of a sleeping pill (eszopiclone, Lunesta)in patients with arthritis of the knee who also suffer from chronic insomnia. This study will test whether Lunesta improves sleep, pain sensitivity, and daytime symptoms in patients with knee pain.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Eszopiclone

Study Locations (1)

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2006-01
Est. Completion 2013-12
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT00374556

The ClinicalTrials.gov registry entry for NCT00374556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (82% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00374556 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00374556 about?

NCT00374556 is a clinical study titled "Insomnia and Osteoarthritis Study". This research is being done to evaluate the effects of a sleeping pill (eszopiclone, Lunesta)in patients with arthritis of the knee who also suffer from chronic insomnia. This study will test whether Lunesta improves sleep, pain sensitivity, and daytime symptoms in patients with knee pain.

What is the current status of trial NCT00374556?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2006-01. Estimated completion is 2013-12.

What conditions does trial NCT00374556 study?

This clinical trial studies the following conditions: Insomnia, Osteoarthritis.

What interventions are being tested in trial NCT00374556?

The interventions under investigation include: Placebo (DRUG), Eszopiclone (DRUG).

Who is sponsoring clinical trial NCT00374556?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00374556 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.